- MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy
- MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
- MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer
- MAIA Biotechnology to Present at the BIO International Convention 2024
- MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
- MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
- MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement
- MAIA Biotechnology Announces $1.00 Million Private Placement
- MAIA Biotechnology to Present at Two Investor Conferences in April 2024
More ▼
Key statistics
On Wednesday, Maia Biotechnology Inc (MAIA:ASQ) closed at 3.39, 313.41% above the 52 week low of 0.82 set on Dec 12, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.32 |
---|---|
High | 3.45 |
Low | 3.31 |
Bid | 3.39 |
Offer | 3.52 |
Previous close | 3.35 |
Average volume | 200.49k |
---|---|
Shares outstanding | 21.84m |
Free float | 17.94m |
P/E (TTM) | -- |
Market cap | 73.15m USD |
EPS (TTM) | -1.57 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 22:00 BST.
More ▼